These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 3875906)
41. Complement activation in patients with primary antiphospholipid syndrome. Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630 [TBL] [Abstract][Full Text] [Related]
42. The effects of protamine on hemodynamics and oxygenation during cardiac surgery. Suwanchinda V; Prakanrattana U J Med Assoc Thai; 1989 May; 72(5):275-9. PubMed ID: 2769122 [TBL] [Abstract][Full Text] [Related]
43. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass. Lazar HL; Bokesch PM; van Lenta F; Fitzgerald C; Emmett C; Marsh HC; Ryan U; Circulation; 2004 Sep; 110(11 Suppl 1):II274-9. PubMed ID: 15364875 [TBL] [Abstract][Full Text] [Related]
44. Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Marcheix B; Carrier M; Martel C; Cossette M; Pellerin M; Bouchard D; Perrault LP Ann Thorac Surg; 2008 Feb; 85(2):530-5. PubMed ID: 18222258 [TBL] [Abstract][Full Text] [Related]
45. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction. Stefaniszyn HJ; Novick RJ; Salerno TA J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047 [TBL] [Abstract][Full Text] [Related]
46. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178 [TBL] [Abstract][Full Text] [Related]
47. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842 [TBL] [Abstract][Full Text] [Related]
48. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators. Tamiya T; Yamasaki M; Maeo Y; Yamashiro T; Ogoshi S; Fujimoto S Ann Thorac Surg; 1988 Jul; 46(1):47-57. PubMed ID: 3382287 [TBL] [Abstract][Full Text] [Related]
49. Absence of complement-mediated events after protamine reversal of heparin anticoagulation. Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362 [TBL] [Abstract][Full Text] [Related]
50. Complement activation and hypersensitivity reactions to dialysis membranes. Hakim RM; Breillatt J; Lazarus JM; Port FK N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276 [TBL] [Abstract][Full Text] [Related]
51. Rapid activation of the complement system by cuprophane depends on complement component C4. Lhotta K; Würzner R; Kronenberg F; Oppermann M; König P Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416 [TBL] [Abstract][Full Text] [Related]
58. [A clinical study of respiratory complication after cardiopulmonary bypass, with special reference to complement activation, WBC and granulocyte elastase]. Nagamine S; Tabayashi K; Haneda K; Mohri H Nihon Geka Gakkai Zasshi; 1994 May; 95(5):348-53. PubMed ID: 8007941 [TBL] [Abstract][Full Text] [Related]
59. Comparison of the hemodynamic changes following left atrial and peripheral venous administration of protamine during cardiac surgery. Suwanchinda V; Prakanrattana U J Med Assoc Thai; 1989 Jun; 72(6):303-6. PubMed ID: 2778419 [TBL] [Abstract][Full Text] [Related]
60. Endotoxemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusion. Taggart DP; Sundaram S; McCartney C; Bowman A; McIntyre H; Courtney JM; Wheatley DJ Ann Thorac Surg; 1994 Feb; 57(2):376-82. PubMed ID: 8311599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]